KRYS logo

KRYS
Krystal Biotech Inc

1,762
Mkt Cap
$8.11B
Volume
434,469.00
52W High
$295.98
52W Low
$122.80
PE Ratio
41.93
KRYS Fundamentals
Price
$269.13
Prev Close
$279.57
Open
$281.32
50D MA
$250.72
Beta
0.97
Avg. Volume
314,786.20
EPS (Annual)
$3.00
P/B
7.12
Rev/Employee
$1.06M
Loading...
Loading...
News
all
press releases
Atle Fund Management AB Acquires 22,033 Shares of Krystal Biotech, Inc. $KRYS
Atle Fund Management AB lifted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 109.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
KYMR Initiates Dosing in Mid-Stage Asthma Study of Lead Candidate
Kymera Therapeutics begins phase IIb dosing of oral KT-621 in eosinophilic asthma patients, targeting STAT6, with top-line BREADTH study data expected in late 2027.
Zacks·5d ago
News Placeholder
Biogen's Autoimmune Disease Candidate Gets FDA's Breakthrough Status
BIIB secures FDA's Breakthrough Therapy status for litifilimab in cutaneous lupus, backed by phase II results, while advancing phase III and broader lupus studies.
Zacks·6d ago
News Placeholder
5 Stocks With Recent Price to Strengthen Your Portfolio
RFIL, BWMX, FET, KRYS and MAMA are five stocks showing sharp recent price strength as markets start 2026 strong.
Zacks·7d ago
News Placeholder
Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why
CRVS stock surges 209% in a month after positive cohort 4 phase I data show durable eczema responses for soquelitinib.
Zacks·8d ago
News Placeholder
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
Krystal Biotech (KRYS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Zacks·9d ago
News Placeholder
Are You Looking for a Top Momentum Pick? Why Krystal Biotech, Inc. (KRYS) is a Great Choice
Does Krystal Biotech, Inc. (KRYS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·12d ago
News Placeholder
Krystal Biotech, Inc. $KRYS Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System trimmed its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 50.4% during the third quarter, according to its most recent 13F filing with...
MarketBeat·12d ago
News Placeholder
SG Americas Securities LLC Cuts Position in Krystal Biotech, Inc. $KRYS
SG Americas Securities LLC reduced its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 73.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·12d ago
News Placeholder
Bank of America Increases Krystal Biotech (NASDAQ:KRYS) Price Target to $318.00
Bank of America boosted their target price on shares of Krystal Biotech from $288.00 to $318.00 and gave the stock a "buy" rating in a report on Thursday...
MarketBeat·13d ago
<
1
2
...
>

Latest KRYS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.